🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🧬 From Localized to Metastatic: Navigating RCC Treatment Join us as experts walk through real-world cases across the RCC continuum—from adjuvant therapy to mRCC. 💡 Risk stratification, treatment decisions & biomarkers in focus. 📍 #ASCO25 | Benjamin L Maughan Scott Capozza, PT, MSPT

Happy the patient voice was included in the ASCO session discussing the real impacts of early onset cancers. Great job by Katie Coleman providing real world solutions to support those going through treatment! We know the issues now we need to implement solutions #ASCO25 OncoAlert

Great talk to Dr. Cathy Eng at ASCO on what the providers interdisciplinary teams need to know when preparing to offer care to younger patients with cancer! #ASCO25 #CRCSM #AYACSM OncoAlert Vanderbilt Health

It was so wonderful to be able to participate in this @asco #asco25 session "Beyond the headlines: The Real Impact of Early-Onset Cancers". Kimryn Rathmell Katie Coleman and Drs. LeeAnne Bailey + Andrew Chang NCICancerTrials Mass General #cancer #earlyonset #cancerresearch

Seen the latest RCC data at #ASCO25? Go deeper with leading kidney cancer experts at #WorldGU25 this August in Nashville, TN. Drs. Brian Rini, MD, Eric Jonasch, Katy Beckermann, Stephanie Berg & Hans Hammers are bringing real-world insights and forward-thinking strategies. #CE-accredited.

At #ASCO25, James CEO Kimryn Rathmell, MD, PhD, shares some quick thoughts on the future of the oncology field, and The James’ role as a leader in cancer care and research.

Excellent conversations on early-onset cancers in our session today at #ASCO2025. Registrants can check out the recording in the link below. Our audience raised so many important issues — make sure early-onset & AYA definitions are more inclusive...(1/3) meetings.asco.org/2025-asco-annu…

🙌 #ASCO25 brought hope for #KidneyCancer patients! Key highlights: 5-yr data from KEYNOTE-564 shows adjuvant pembrolizumab boosting survival (87.7% OS vs 82.3% placebo). PDIGREE trial explores adaptive treatments, personalizing care. New biomarkers & imaging like CA-IX offer

#ASCO25 @asco ➡️ advancing #CancerResearch but it also ➡️ #friendships that can last a lifetime. 🫶Hagen Kennecke Smitha Krishnamurthi Kathy Walsh, MD, MAEd Kai-Keen Shiu Dr. jordan berlin Naveen Pemmaraju, MD Van Morris, MD Eric Lander, MD Joseph Vento, MD, MS Sharlene Gill, MD, MPH, MBA, FASCO Dr. Shubham Pant Dr. Nina Niu Sanford David S. Hong MD

Dear Colleagues at #ASCO25 As ALWAYS, it is a pleasure for OncoAlert 🚨 to be around to capture yet another GREAT Uromigos discussion by Tom Powles 🇬🇧& Brian Rini, MD 🇺🇸 Here they are lakeside discussing Final Results of IO-Based Combination in mRCC Ping OncoAlert GU Faculty

🌟Excited to see OncoAlert sharing another insightful discussion by Uromigos on IO-based combinations for mRCC at #ASCO25! These discussions are vital and as a patient I’m glad they are available to see👏🏻👏🏻 The focus on final results is crucial because it means we're getting

Encouraging interim results of the phase 1/2 trial of the HPK1 inhibitor NDI-101150 were presented by David Braun for patients with clear cell renal cell carcinoma (ccRCC) showing promising antitumor activity #ASCO25. Smilow Cancer Hospital OncoAlert meetings.asco.org/abstracts-pres…

Feels Like Summer

Dear Colleagues Thank you for Another amazing day at our Annual #OncoAlert5k 🏃‍♀️at #ASCO25 , we look forward to seeing you all soon for another great day of camaraderie Safe Travels Home🏡 Gil Morgan, MD & OncoAlert #OncoAlertAF Dra. María Natalia Gandur Quiroga Alizée Camps - - Maléa Biagio Ricciuti, MD, PhD

Chicago in June is beautiful and we were happy to be there for #ASCO25. Impressed with the clinicians, researchers, advocates, and all those raising their voices to support #cancerresearch, #kidneycancer, and progress on behalf of patients! Already looking forward to next year!

Leaving Chicago & #ASCO25 with full heart. Reminded of our common purpose to #curecancer and make a difference for our patients. Thanks ASCO for a wonderful data, networking, & inspiration filled weekend!

Something has to be done about healthcare here in the US. • #USHealthcare #HealthcareCrisis #HealthInequity #MedicareForAll #HealthcareReform 22-year-old dies after being unable to afford asthma inhaler nbcnews.com/nightly-news/v…

Steps can easily turn into another thing to chase, and it's not what we’re about. That's why we avoided the ring visual, as it subtly pushes you to complete it, no matter your state. Instead, we chose a softer visual that should support awareness, not pressure. #Tminus1

The Film & The Photos